|
US2603643A
(en)
|
1947-03-13 |
1952-07-15 |
Hoffmann La Roche |
2-amino-4-hydroxy-6-polyhydroxyalkyl pteridine and methods of oxidizing same
|
|
US2601215A
(en)
|
1948-03-17 |
1952-06-17 |
American Cyanamid Co |
Process of preparing dihydropterins
|
|
US2541717A
(en)
|
1948-10-18 |
1951-02-13 |
Upjohn Co |
Pterine imines
|
|
US2568685A
(en)
|
1950-07-22 |
1951-09-18 |
Upjohn Co |
2-amino-4-hydroxy-6-omega-carboxytrihydroxy-propylpteridines
|
|
US2955110A
(en)
|
1955-01-13 |
1960-10-04 |
American Cyanamid Co |
Substituted pteridines and method of preparing the same
|
|
US3505329A
(en)
|
1968-02-06 |
1970-04-07 |
Smithkline Corp |
Process for the synthesis of biopterin
|
|
GB2056459B
(en)
|
1979-07-04 |
1983-03-09 |
Daiichi Radioisotope Lab |
Pterin derivatives and an assay method for determining pterins
|
|
US4252822A
(en)
|
1979-12-26 |
1981-02-24 |
Children's Hospital Medical Center |
Method for treating phenylketonuria
|
|
JPS5883691A
(ja)
|
1981-11-13 |
1983-05-19 |
Kanegafuchi Chem Ind Co Ltd |
１′，２′−ジアシル−（６ｒ，ｓ）−５，６，７，８−テトラヒドロ−ｌ−ビオプテリンおよびその製法
|
|
JPS5925323A
(ja)
|
1982-03-03 |
1984-02-09 |
鐘淵化学工業株式会社 |
プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
|
|
JPS5921685A
(ja)
|
1982-07-28 |
1984-02-03 |
Suntory Ltd |
Ｌ―エリスロ―バイオプテリンの製造法
|
|
EP0108890B1
(en)
|
1982-09-20 |
1988-12-07 |
The Wellcome Foundation Limited |
Pharmaceutically active pteridine derivatives
|
|
GB8318833D0
(en)
|
1983-07-12 |
1983-08-10 |
Wellcome Found |
Chemical compounds
|
|
ZA836957B
(en)
|
1982-09-20 |
1985-04-24 |
Wellcome Found |
Neurologically active chemical compounds
|
|
US5196533A
(en)
|
1983-04-11 |
1993-03-23 |
South Alabama Medical Science Foundation, Usa |
Cyclization of 5 amino-pyrimidines to quinoid 6,6 disubstituted dihydropteridines
|
|
US4587340A
(en)
|
1983-09-19 |
1986-05-06 |
Burroughs Wellcome Co. |
Biopterin analogs
|
|
JPS60178887A
(ja)
|
1984-02-23 |
1985-09-12 |
Kanegafuchi Chem Ind Co Ltd |
５，６，７，８−テトラヒドロ−ｌ−ビオプテリンの製造法
|
|
JPS60199889A
(ja)
|
1984-03-24 |
1985-10-09 |
Kanegafuchi Chem Ind Co Ltd |
５，６，７，８−テトラヒドロ−ｌ−エリスロ−ビオプテリンの硫酸塩およびその製法
|
|
US4550109A
(en)
|
1984-05-31 |
1985-10-29 |
The Board Of Regents, The University Of Texas System |
Lipoidal biopterin compounds
|
|
DE3437944A1
(de)
|
1984-10-17 |
1986-07-31 |
Biotest-Serum-Institut Gmbh, 6000 Frankfurt |
Verwendung von pterinen zur steigerung der aktivitaet von lymphokinen und anderen blutfaktoren, sowie ein diagnostisches oder therapeutisches praeparat, das pterine in kombination mit lymphokinen enthaelt
|
|
US4713454A
(en)
|
1985-01-28 |
1987-12-15 |
Shiratori Pharmaceutical Co., Ltd. |
Preparation process of (6R)-tetrahydro-L-biopterin
|
|
JPS61172877A
(ja)
*
|
1985-01-28 |
1986-08-04 |
Shiratori Seiyaku Kk |
（６ｒ）−テトラヒドロ−ｌ−バイオプテリンの製造方法
|
|
JPS61277618A
(ja)
|
1985-06-04 |
1986-12-08 |
Suntory Ltd |
自閉症治療剤
|
|
ATE66147T1
(de)
|
1987-02-13 |
1991-08-15 |
Allergan Pharma |
Verwendung von pteridinen und/oder purinen oder eines xanthinoxidase-hemmers zur herstellung eines arzneimittels zur behandlung von genetisch bedingten degenerativen netzhauterkrankungen.
|
|
JP2588191B2
(ja)
*
|
1987-04-24 |
1997-03-05 |
サントリー株式会社 |
悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
|
|
DE3853711T2
(de)
|
1987-11-30 |
1996-01-11 |
Vitamin Kenkyusho Kk |
Zwischenverbindungen für die Synthese von 5,6,7,8-Tetrahydro-L-erythro-biopterin und seiner Derivate.
|
|
EP0349204A3
(en)
|
1988-06-28 |
1991-08-07 |
Bend Research, Inc. |
Use and regeneration of reagents using coupled reactions and permselective barriers
|
|
JP2843592B2
(ja)
|
1989-02-28 |
1999-01-06 |
日清製粉株式会社 |
Ｌ−リボース誘導体
|
|
US5554647A
(en)
|
1989-10-12 |
1996-09-10 |
Perricone; Nicholas V. |
Method and compositions for treatment and/or prevention of skin damage and aging
|
|
WO1991012814A1
(en)
|
1990-02-28 |
1991-09-05 |
E.I. Du Pont De Nemours And Company |
Activation of monocyte/macrophages
|
|
JP3137333B2
(ja)
|
1990-07-21 |
2001-02-19 |
サントリー株式会社 |
テトラヒドロビオプテリンの製法およびそれに用いる酵素
|
|
DE4037447C2
(de)
|
1990-11-24 |
1994-06-01 |
Milupa Ag |
Phenylalaninfreies Diätetikum für juvenile und adulte Personen mit Phenylketonurie sowie ein Verfahren zu seiner Herstellung
|
|
JPH04210624A
(ja)
|
1990-12-11 |
1992-07-31 |
Shigenobu Sakata |
薬用効果を有する入浴剤及び化粧水
|
|
ATE180493T1
(de)
|
1991-11-16 |
1999-06-15 |
Suntory Ltd |
Rezeptor für 6(r)-l-erythro-5,6,7,8- tetrahydrobiopterin
|
|
US5877176A
(en)
|
1991-12-26 |
1999-03-02 |
Cornell Research Foundation, Inc. |
Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
|
|
JP2534423B2
(ja)
|
1991-12-26 |
1996-09-18 |
コーネル・リサーチ・ファンデーション・インコーポレイテッド |
酸化窒素の過剰生産から生じる血管失調を阻止する阻害剤
|
|
US5198547A
(en)
|
1992-03-16 |
1993-03-30 |
South Alabama Medical Science Foundation, Usa |
Process for N5-formylating tetrahydropteridines
|
|
DE4215275A1
(de)
|
1992-05-09 |
1993-11-11 |
Merck Patent Gmbh |
Mittel und Verfahren zur Behandlung von Körperflüssigkeiten bei der Bestimmung von Neopterin
|
|
US6251953B1
(en)
|
1992-10-30 |
2001-06-26 |
Andrew Brookner |
Beta-carotene therapy of individuals having abnormal immunological and serological indices, and individuals having infections and diseases causing changes therein
|
|
US5658565A
(en)
|
1994-06-24 |
1997-08-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Inducible nitric oxide synthase gene for treatment of disease
|
|
EP0670902A1
(en)
|
1992-11-25 |
1995-09-13 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
cDNA CLONE FOR HUMAN INDUCIBLE NITRIC OXYDE SYNTHASE AND PROCESS FOR PREPARING SAME
|
|
US5830461A
(en)
|
1992-11-25 |
1998-11-03 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Methods for promoting wound healing and treating transplant-associated vasculopathy
|
|
US20020061862A1
(en)
|
1992-11-25 |
2002-05-23 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Inducible nitric oxide synthase for treatment of disease
|
|
US5468772A
(en)
|
1993-03-10 |
1995-11-21 |
Pharmagenesis, Inc. |
Tripterinin compound and method
|
|
DE4308739C1
(de)
|
1993-03-19 |
1994-06-23 |
Henning Berlin Gmbh |
Pterinderivate, ihre Herstellung und ihre Verwendung
|
|
EP0689449B1
(fr)
|
1993-03-19 |
2002-10-30 |
Vacsyn S.A. |
Compositions pour l'application en therapeutique humaine, caracterisees par l'association d'un muramyl-peptide a une cytokine
|
|
US5449688A
(en)
|
1993-03-30 |
1995-09-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of treating chronic inflammatory diseases
|
|
US5945452A
(en)
|
1993-06-11 |
1999-08-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
|
|
US5502050A
(en)
|
1993-11-29 |
1996-03-26 |
Cornell Research Foundation, Inc. |
Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
|
|
TW282398B
(pt)
|
1993-12-22 |
1996-08-01 |
Bristol Myers Squibb Co |
|
|
JP3347870B2
(ja)
*
|
1994-04-15 |
2002-11-20 |
三菱電機株式会社 |
超電導マグネット並びに該マグネット用の蓄冷型冷凍機
|
|
DE4418096A1
(de)
|
1994-05-24 |
1995-11-30 |
Cassella Ag |
Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase
|
|
EP0722731B1
(en)
|
1994-08-05 |
2002-06-05 |
Suntory Limited |
Remedy for spinocerebellar degeneration
|
|
US5643586A
(en)
|
1995-04-27 |
1997-07-01 |
Perricone; Nicholas V. |
Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds
|
|
US5744340A
(en)
|
1995-06-09 |
1998-04-28 |
Schering Corporation |
Expression of human inducible nitric oxide synthase
|
|
SE506533C2
(sv)
|
1995-07-03 |
1998-01-12 |
Birger Andersson |
En process för in vitro analys av substansers toxiska och allergena egenskaper samt användning av neopterin för att skilja mellan allergiska immunreaktioner
|
|
US5879690A
(en)
|
1995-09-07 |
1999-03-09 |
Perricone; Nicholas V. |
Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
|
|
JP2711828B2
(ja)
|
1996-06-25 |
1998-02-10 |
白鳥製薬株式会社 |
（６ｒ）−テトラヒドローｌ−バイオプテリン塩酸塩の製造法
|
|
US5856158A
(en)
|
1996-07-05 |
1999-01-05 |
University Of Iowa Research Foundation |
Purified nitric oxide synthase from rat brain
|
|
US20020076782A1
(en)
|
1996-07-05 |
2002-06-20 |
John P.N. Rosazza |
Purified nitric oxide synthase
|
|
EP0884317B1
(en)
|
1996-07-31 |
2005-05-18 |
Cmic Co., Ltd. |
Active oxygen scavengers containing pterin derivatives
|
|
GB9617990D0
(en)
|
1996-08-29 |
1996-10-09 |
Scotia Holdings Plc |
Treatment of pain
|
|
DE69725721T3
(de)
|
1996-08-30 |
2007-10-31 |
Daiichi Asubio Pharma Co., Ltd. |
Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst sind
|
|
AU6237798A
(en)
|
1996-12-24 |
1998-07-17 |
Research Development Foundation |
Ricin inhibitors and methods for use thereof
|
|
US6562969B1
(en)
|
1996-12-24 |
2003-05-13 |
Research Development Foundation |
Ricin inhibitors and methods for use thereof
|
|
US6428990B1
(en)
|
1997-04-11 |
2002-08-06 |
Abbott Laboratories |
Human desaturase gene and uses thereof
|
|
US5846775A
(en)
|
1997-04-22 |
1998-12-08 |
Incyte Pharmaceuticals, Inc. |
GTP cyclohydrolase I regulatory protein
|
|
CH693255A5
(de)
|
1997-06-13 |
2003-05-15 |
Eprova Ag |
Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
|
|
US5922713A
(en)
|
1997-06-26 |
1999-07-13 |
Werner; Ernst |
Inhibition of nitric oxide synthase
|
|
ATE201412T1
(de)
*
|
1997-10-06 |
2001-06-15 |
Ernst Werner |
Pteridinderivate als no synthase-hemmer
|
|
AU1189399A
(en)
|
1997-10-15 |
1999-05-03 |
Uab Research Foundation |
Bathocuproine treatment of neurologic disease
|
|
JP4306825B2
(ja)
|
1998-02-27 |
2009-08-05 |
アスビオファーマ株式会社 |
インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
|
|
DE69925225T2
(de)
|
1998-02-27 |
2006-02-23 |
Daiichi Suntory Pharma Co., Ltd. |
Propylaxe und behandlung der arzneimittel induzierten nierenstörungen
|
|
US6180597B1
(en)
|
1998-03-19 |
2001-01-30 |
Brigham And Women's Hospital, Inc. |
Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase function inhibitors
|
|
US6162914A
(en)
|
1998-04-24 |
2000-12-19 |
Cerbios-Pharma S.A. |
Process for the reduction of pterins
|
|
US6117872A
(en)
|
1998-06-23 |
2000-09-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
|
|
US6423751B1
(en)
|
1998-07-14 |
2002-07-23 |
The Brigham And Women's Hospital, Inc. |
Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
|
|
US6656925B2
(en)
|
1998-09-09 |
2003-12-02 |
Advanced Medical Instruments |
Composition and method of treating arthritis
|
|
US6346519B1
(en)
|
1998-09-09 |
2002-02-12 |
Advanced Medical Instruments |
Method and composition for treating arthritis
|
|
US7276506B2
(en)
|
1998-12-28 |
2007-10-02 |
4 Aza Bioscience Nv |
Immunosuppressive effects of pteridine derivatives
|
|
US6319905B1
(en)
|
1998-12-29 |
2001-11-20 |
Cell Genesys, Inc. |
Method of controlling L-Dopa production and of treating dopamine deficiency
|
|
US6486168B1
(en)
|
1999-01-08 |
2002-11-26 |
3M Innovative Properties Company |
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
|
|
US20020058674A1
(en)
|
1999-01-08 |
2002-05-16 |
Hedenstrom John C. |
Systems and methods for treating a mucosal surface
|
|
HU229441B1
(en)
|
1999-01-08 |
2013-12-30 |
3M Innovative Properties Co |
Formulations and methods for treating mucosal associated conditions with an immune response modifier
|
|
US6200758B1
(en)
|
1999-02-19 |
2001-03-13 |
New York State Office Of Mental Health |
Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders
|
|
WO2000056328A1
(en)
|
1999-03-19 |
2000-09-28 |
Enos Pharmaceuticals, Inc. |
Increasing cerebral bioavailability of drugs
|
|
US6288535B1
(en)
|
1999-07-06 |
2001-09-11 |
Jacob Chass |
Hall effect, shaft angular position sensor with asymmetrical rotor
|
|
ES2313900T3
(es)
|
1999-07-28 |
2009-03-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nicotina en angiogenesis y vasculogenesis terapeutica.
|
|
GB2355191A
(en)
|
1999-10-12 |
2001-04-18 |
Laxdale Ltd |
Combination formulations for fatigue, head injury and strokes
|
|
US20020155445A1
(en)
|
1999-12-16 |
2002-10-24 |
Jarvik Jonathan W. |
Methods and products for peptide based DNA sequence identification and analysis
|
|
AUPQ598300A0
(en)
|
2000-03-03 |
2000-03-23 |
Citrus Sensation Pty Ltd |
Citrus fruit preservative
|
|
US6576105B1
(en)
|
2000-03-31 |
2003-06-10 |
Truman State University |
Pteridine analysis by capillary electrophoresis using laser-induced fluorescence detection
|
|
CA2404909A1
(en)
|
2000-04-12 |
2001-10-25 |
Caroline L. Jones |
Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity
|
|
US6544994B2
(en)
*
|
2000-06-07 |
2003-04-08 |
Eprov Ag |
Pharmaceutical preparation for treating or preventing cardiovascular or neurological disorders by modulating of the activity of nitric oxide synthase
|
|
WO2002000933A2
(en)
|
2000-06-23 |
2002-01-03 |
Interleukin Genetics, Inc. |
Screening assays for identifying modulators of the inflammatory or immune responses
|
|
AU2001284865A1
(en)
|
2000-08-14 |
2002-02-25 |
Joan M. Fallon |
Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
|
|
EP1314782B1
(en)
|
2000-08-31 |
2009-03-18 |
Asubio Pharma Co., Ltd. |
Process for producing biopterins
|
|
DE10043845A1
(de)
|
2000-09-06 |
2002-03-14 |
Gruenenthal Gmbh |
Verfahren zur Messung der Aktivität der NO-Synthase
|
|
US6689385B2
(en)
|
2000-11-03 |
2004-02-10 |
Chronorx Llc |
Formulations for the treatment of insulin resistance and type 2 diabetes mellitus
|
|
UA80393C2
(uk)
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
|
|
US6537992B2
(en)
|
2001-01-05 |
2003-03-25 |
John D. Parker |
Regulation of organic nitrate tolerance
|
|
TWI241190B
(en)
|
2001-02-13 |
2005-10-11 |
Aventis Pharma Gmbh |
4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
|
|
US6693094B2
(en)
|
2001-03-22 |
2004-02-17 |
Chrono Rx Llc |
Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus
|
|
US6500857B1
(en)
|
2001-08-16 |
2002-12-31 |
Nicholas V. Perricone |
Subcutaneous muscle treatment using electronic stimulation and topical compositions
|
|
US20030078231A1
(en)
|
2001-06-22 |
2003-04-24 |
Wilburn Michael D. |
Orthomolecular sulpho-adenosylmethionine derivatives with antioxidant properties
|
|
US20030004125A1
(en)
|
2001-06-22 |
2003-01-02 |
Hirst David G. |
Inducible gene
|
|
US6787178B2
(en)
*
|
2001-07-09 |
2004-09-07 |
Kiyoshi Yamamoto |
Health drink and method for production thereof
|
|
JP4082888B2
(ja)
|
2001-10-17 |
2008-04-30 |
広栄化学工業株式会社 |
ビアリール化合物の製造法
|
|
CH696628A5
(de)
*
|
2002-02-26 |
2007-08-31 |
Eprova Ag |
Verwendung von Folaten zur Herstellung einer Zubereitung geeignet zur Vorbeugung und Behandlung von Entzündungen und entzündungsassoziierter Krankheiten, im Speziellen zur Beeinflussung der
|
|
DE10260263A1
(de)
|
2002-12-20 |
2004-07-15 |
Biocrates Life Sciences Gmbh |
Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
|
|
US20050137141A1
(en)
|
2003-10-24 |
2005-06-23 |
John Hilfinger |
Prodrug composition
|
|
US20070167353A1
(en)
|
2003-10-24 |
2007-07-19 |
John Hilfinger |
Prodrug composition
|
|
PL1708690T3
(pl)
|
2003-11-17 |
2017-01-31 |
Biomarin Pharmaceutical Inc. |
Leczenie fenyloketonurii za pomocą BH4
|
|
EP1687308B1
(en)
*
|
2003-11-17 |
2019-06-12 |
Merck & Cie |
Process for preparating (6R)-L-erythrotetrahydrobiopterin hydrochloride crystalline form B from other crystalline forms
|
|
JP5184783B2
(ja)
|
2003-11-17 |
2013-04-17 |
バイオマリン ファーマシューティカル インコーポレイテッド |
テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法
|
|
US7067659B2
(en)
|
2004-04-23 |
2006-06-27 |
Duke University |
Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
|
|
US20080207624A1
(en)
|
2004-05-11 |
2008-08-28 |
Osamu Sugita |
Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia
|
|
AU2005259961B2
(en)
|
2004-06-25 |
2012-05-17 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia
|
|
KR20070084270A
(ko)
*
|
2004-11-17 |
2007-08-24 |
바이오마린 파머수티컬 인크. |
안정한 정제 제형물
|
|
JP2008523090A
(ja)
|
2004-12-08 |
2008-07-03 |
バイオマリン ファーマシューティカル インコーポレイテッド |
新生児肺高血圧症の治療のための方法および組成物
|
|
US20060194808A1
(en)
|
2005-01-14 |
2006-08-31 |
Chronorx Llc, An Alaska Limited Liability Company |
Clinical applications of tetrahydrobiopterin, lipoic acid and their salts and methods of preparing tetrahydrobiopterin bis-lipoate
|
|
WO2007067570A1
(en)
|
2005-12-05 |
2007-06-14 |
Biomarin Pharmaceutical Inc. |
Methods and compositions for the treatment of disease
|
|
WO2007072911A1
(ja)
|
2005-12-22 |
2007-06-28 |
Asubio Pharma Co., Ltd. |
塩酸サプロプテリンの生体内吸収性を向上させた製剤
|
|
US20080075666A1
(en)
|
2006-08-25 |
2008-03-27 |
Dudley Samuel C Jr |
Methods and compositions for treating diastolic dysfunction
|
|
EP3539560A1
(en)
|
2007-02-22 |
2019-09-18 |
Children's Hospital & Research Center at Oakland |
Fatty acid formulations and methods of use thereof
|
|
JP5226960B2
(ja)
*
|
2007-02-28 |
2013-07-03 |
株式会社スクウェア・エニックス |
ゲーム装置及び仮想カメラの制御方法、並びにプログラム及び記録媒体
|